Fogarty Presents Global Health Data Guru Dr. Hans Rosling

Dr. Hans Rosling standing in front of a projected slide, pointing to figures on a colorful graph with unreadable data

Dr. Hans Rosling turns boring numbers into
enjoyable animations that make sense of the
world’s global health gaps.

Dr. Hans Rosling, Google collaborator and guru of global health data, presented The New Health Gap: Science for Emerging Economies vs. the Bottom Billion on Monday, February 22, 2010, on the NIH Campus in Bethesda, Maryland.

Rosling is co-founder of Gapminder, a non-profit organization dedicated to promoting a fact-based world view through increased use and understanding of freely accessible public statistics. Gapminder developed the Trendalyzer software that converts international statistics into moving, interactive and enjoyable graphics. Google acquired the software and has expanded the effort, adding a Motion Chart and Google Gadget. Rosling uses these animated graphics in talks that are both humorous and deadly serious, with the goal of promoting sustainable global development and encouraging achievement of the UN’s Millennium Development Goals.

Also a professor of international health at Sweden’s Karolinska Institute, Rosling co-founded Médecines sans Frontier Sweden. While serving as a doctor in Mozambique from 1979 to 1981, he discovered konzo, a new epidemic paralytic disease. He spent the next two decades investigating the cause, which he traced to the consumption of toxic, ill-processed cassava roots combined with hunger and poverty. In addition, he has written a text book on global health and has initiated university collaborations with Asia and Africa.

Partners

Dr. Rosling visited NIH as a Fogarty International Center Scholar-in-Residence, concluding the Center’s 40th anniversary activities. The events have been sponsored by the Foundation for NIH with generous support from Lilly, the Abbott Fund, Bristol-Myers Squibb Foundation, ExxonMobil, Pepsico, Aeras Global TB Vaccine Foundation, the Burroughs Wellcome Fund, Merck, Pfizer, Tibotec and the United Nations Foundation.

Footer